The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Economic factors as well as clinical outcomes may influence castrate-resistant prostate cancer treatment practice.
N. J. Combates
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
J. Beetsch
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
L. Nicacio
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi